A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A
Clinical trial NCT03020160 · COMPLETED
Trial details
- NCT number
- NCT03020160
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-30
- Primary completion
- 2017-12-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.